Trending Now
We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
Omicron & the undoing of China's COVID strategy
Omicron is here. The bad news is that it's more contagious. The good news is that mRNA vaccines work against death and hospitalization. COVID may soon become endemic in some parts of the world.
Not in China, where Xi Jinping's zero-COVID approach faces its toughest test to date with omicron. Why? Because China lacks mRNA jabs, and so few Chinese people have gotten COVID that overall protection is very low.
Get ready for a wave of lockdowns that'll severely disrupt the world's second-largest economy — just a month out from the Beijing Winter Olympics.
That could spell disaster for Beijing, Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations, tells Ian Bremmer on this week's episode of GZERO World.
Still, he says zero COVID remains popular with most Chinese people.
If things get really bad, though, Huang believes China will pivot to living with the virus, especially as the cost of keeping zero COVID in the age of omicron becomes too high. He thinks that's the right move for Xi.
Indeed, Huang expects China to start reversing course soon after the Games, and when the pandemic becomes endemic in other parts of the world. Beijing will throw in the towel on zero tolerance in 1-2 years, max.
Also, a look at vaccine incentives around the world. Do prizes like cows and brothel visits actually convince holdouts to get the jab?
Subscribe to GZERO Media's YouTube channel to get notifications when new episodes are published.
- Is omicron the best thing that's happened since the pandemic started ... ›
- China's pandemic playbook will fail with Omicron — Laura Yasaitis ... ›
- China's coming COVID crisis? - GZERO Media ›
- The problem with China's Zero COVID strategy | GZERO World ... ›
- Ian Bremmer: Zero COVID no longer works, and China will pay a ... ›
- End of globalization for Russia - GZERO Media ›
- Podcast: China's uphill battles, from Putin to COVID: Newsweek's Melinda Liu - GZERO Media ›
- COVID immunity gap could spell disaster for China — global health expert - GZERO Media ›
Podcast: The problem with China’s Zero COVID strategy
Listen: Xi Jinping's zero-COVID approach faces its toughest test to date with omicron. Why? Because China lacks mRNA jabs, and so few Chinese people have gotten COVID that overall protection is very low. A wave of lockdowns could disrupt the world's second-largest economy — just a month out from the Beijing Winter Olympics.
That could spell disaster for Beijing, Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations, tells Ian Bremmer on the GZERO World podcast. If things get really bad, though, Huang believes China will pivot to living with the virus, especially as the cost of keeping zero COVID in the age of omicron becomes too high.
Subscribe to the GZERO World Podcast on Apple Podcasts, Spotify, Stitcher, or your preferred podcast platform, to receive new episodes as soon as they're published.- China's coming COVID crisis? - GZERO Media ›
- Kevin Rudd: COVID has made Xi Jinping zero-risk - GZERO Media ›
- Ian Bremmer: Zero COVID no longer works, and China will pay a ... ›
- How China decides to handle omicron will have global implications – Yanzhong Huang - GZERO Media ›
- Eastern European leaders visit Kyiv in unprecedented show of support - GZERO Media ›
- China isn't budging on zero-COVID - GZERO Media ›
- China’s discontent & the Russia distraction - GZERO Media ›
- China's year of unpredictability - GZERO Media ›
- COVID protests spread in China - GZERO Media ›
- Podcast: How we overcome infectious disease with a public health renaissance - GZERO Media ›
- Podcast: No Empire lasts forever: How China’s rise could trigger a new world order - GZERO Media ›
- COVID immunity gap could spell disaster for China — global health expert - GZERO Media ›
- Omicron & the undoing of China's COVID strategy - GZERO Media ›
The Graphic Truth: The unequal road to herd immunity
When will we return to a pre-pandemic normal by achieving COVID-19 herd immunity? Well, that depends where you live. While a host of wealthy nations that stockpiled vaccines and have already started rolling them out are planning for a post-COVID recovery in the near-term, the bulk of middle-income states will have to wait many months until the vaccine is rolled out to large swaths of the population. Most developing nations, meanwhile, as well as countries that will only get drugs through the global COVAX facility, may still be living with the coronavirus for three more years, according to predictions by The Economist Intelligence Unit. We compare when the pandemic is likely to end in different groups of countries, based on their access to vaccines and rollout plans.
COVID vaccine development could be damaged by politics, says former US Surgeon General
"When we already have enough challenges with people understanding the science behind vaccines, we cannot afford to allow the development and approval of a vaccine to be further politicized," Dr. Vivek Murthy told Ian Bremmer on GZERO World. The former US Surgeon General expressed concerns that politics could hurt the process of development and distribution while shaking public confidence. He also discusses the current state of development for a COVID-19 vaccine, and possible scenarios for its efficacy once available.
Ask an epidemiologist: Harvard's Marc Lipsitch answers your COVID questions
Do masks really protect us? Are children less vulnerable to COVID-19? And why do scientists hope you avoid indoor bars? This week, GZERO World is taking all of our burning questions about the latest in the pandemic to a Harvard epidemiologist. Marc Lipsitch is a Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health and the Director of the Center for Communicable Disease Dynamics. So, he knows his stuff!
Ian Bremmer: The United States isn't Sweden
I don't usually respond directly to individual op-eds but when it's Tom Friedman in The New York Times, and you're talking about how we respond to global coronavirus, well, it seems like it's a good time to weigh in. The op-ed in question: "Is Sweden Doing It Right?" And asking essentially, on the back of that, therefore, should we be Sweden, the United States? Is that the direction that we want to go in? And by the way, do we know what Sweden actually did? And this is really one that you need to take a red pen to.
First of all, not true that Sweden just opened everything up and allowed a herd immunity. Some schools were closed, mass gatherings were canceled, travel within the country has mostly stopped. So, it's very different from the idea that Sweden is business as usual. And as a consequence, it's very misleading to think that if we were Sweden, that our economy wouldn't have taken a hit. It would have taken a very significant hit, probably still an unprecedented hit since the Great Depression. You would have been shutting down an awful lot of real business. But it wouldn't have been as bad as it is right now. So, that's one important point.
A second is, could we do what Sweden has done? We're a much larger country of red and blue states that have control of their individual states, of their school systems, of their budgets, of their police forces. And they are the ones that make the rules. I mean, Trump can say "I have ultimate authority," but it's not Trump's authority to make. So, I mean, you know, are we asking should we have 50 individual states that all choose to be Sweden? Well, some of them kind of did, if you think about what they did and didn't put in place. Others didn't. It's not going to be a federal government decision.
And also, the preconditions in the United States if you want to do Sweden, I mean, no mention here of obesity. No mention of type 2 diabetes. The fact that American health care is nowhere close to what Sweden's is. And American trust in that system is nowhere close to what Sweden's is. And the inequalities in the United States, this disease on the back of African Americans to a much greater degree. Sweden, so much more homogeneous. Makes the two systems so, so different.
And then, what is it that Sweden actually has gotten out of it? About 25% of Stockholm, it is believed, now has antibodies. Which means that on the back of this policy, they have a quarter of their population that has already been exposed to, gotten the disease. Does that get you herd immunity? The science is out on what herd immunity is going to be when it comes to coronavirus. Yeah, 60% seems to be tipping point. You need at least that to be able to get immunity for the country. But you also need to know whether that 60% that just got coronavirus were asymptomatic or 60% that had it and had moderate to severe symptoms. And doctors do not agree on that at this point. And if it turns out it's the latter, then Sweden has had this experiment and they're nowhere close to herd immunity. Not to mention the fact that we're only talking about Stockholm and not the rest of the country, which okay, Tom and I probably only go to Stockholm when we go to Sweden, but the Swedes actually go across the whole damn country. So, you need to pay attention to all of that as well.
It's really important, I think, for us not to hold up the Swedish model as somehow some proven way to get the economy working, have a few more people end up, older people end up in critical condition or die, but everything else is fine, and we should now look carefully at that. What we need to do is recognize that the United States is not Sweden. Could not be Sweden. Sweden is not Sweden in terms of the way that we're kind of mythologizing it right now.